• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌分期中的影像学检查:当前作用与未来展望

Imaging in prostate cancer staging: present role and future perspectives.

作者信息

Pinto Francesco, Totaro Angelo, Palermo Giuseppe, Calarco Alessandro, Sacco Emilio, D'Addessi Alessandro, Racioppi Marco, Valentini AnnaLia, Gui Benedetta, Bassi PierFrancesco

机构信息

Department of Urology, Catholic University of the Sacred Heart, Rome, Italy.

出版信息

Urol Int. 2012;88(2):125-36. doi: 10.1159/000335205. Epub 2012 Jan 27.

DOI:10.1159/000335205
PMID:22286304
Abstract

Despite recent improvements in detection and treatment, prostate cancer continues to be the most common malignancy and the second leading cause of cancer-related mortality. Thus, although survival rate continues to improve, prostate cancer remains a compelling medical health problem. The major goal of prostate cancer imaging in the next decade will be more accurate disease characterization through the synthesis of anatomic, functional, and molecular imaging information in order to plan the most appropriate therapeutic strategy. No consensus exists regarding the use of imaging for evaluating primary prostate cancer. However, conventional and functional imaging are expanding their role in detection and local staging and, moreover, functional imaging is becoming of great importance in oncologic management and monitoring of therapy response. This review presents a multidisciplinary perspective on the role of conventional and functional imaging methods in prostate cancer staging.

摘要

尽管近年来在检测和治疗方面有所改进,但前列腺癌仍然是最常见的恶性肿瘤,也是癌症相关死亡的第二大主要原因。因此,虽然生存率持续提高,但前列腺癌仍然是一个紧迫的医疗健康问题。未来十年前列腺癌成像的主要目标将是通过整合解剖、功能和分子成像信息,更准确地对疾病进行特征描述,以便制定最合适的治疗策略。关于使用成像技术评估原发性前列腺癌,目前尚无共识。然而,传统成像和功能成像在检测和局部分期中的作用正在扩大,此外,功能成像在肿瘤管理和治疗反应监测中变得越来越重要。本文综述从多学科角度阐述了传统成像和功能成像方法在前列腺癌分期中的作用。

相似文献

1
Imaging in prostate cancer staging: present role and future perspectives.前列腺癌分期中的影像学检查:当前作用与未来展望
Urol Int. 2012;88(2):125-36. doi: 10.1159/000335205. Epub 2012 Jan 27.
2
The future of molecular and functional imaging in prostate cancer.前列腺癌分子与功能成像的未来。
Arch Esp Urol. 2019 Mar;72(2):150-156.
3
Imaging prostate cancer: a multidisciplinary perspective.前列腺癌成像:多学科视角
Radiology. 2007 Apr;243(1):28-53. doi: 10.1148/radiol.2431030580.
4
Imaging of prostate cancer.前列腺癌的影像学检查
Radiol Clin North Am. 2007 Jan;45(1):207-22. doi: 10.1016/j.rcl.2006.10.008.
5
Prostate cancer imaging.前列腺癌成像
Semin Roentgenol. 2006 Apr;41(2):139-49. doi: 10.1053/j.ro.2006.03.001.
6
Prostate cancer imaging: what the urologist wants to know.前列腺癌成像:泌尿科医生想了解的内容。
Radiol Clin North Am. 2012 Nov;50(6):1015-41. doi: 10.1016/j.rcl.2012.08.004.
7
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
8
Imaging prostate cancer.前列腺癌成像
Radiol Clin North Am. 2000 Jan;38(1):59-85, viii. doi: 10.1016/s0033-8389(05)70150-0.
9
Prospects in radionuclide imaging of prostate cancer.前列腺癌放射性核素成像的展望。
Prostate. 2012 Aug 1;72(11):1262-72. doi: 10.1002/pros.22462. Epub 2011 Nov 29.
10
How does endorectal MRI, PET-CT and transrectal ultrasound contribute to diagnosis and management of localized prostate cancer.直肠内MRI、PET-CT和经直肠超声如何有助于局限性前列腺癌的诊断和管理?
Arch Esp Urol. 2011 Oct;64(8):746-64.

引用本文的文献

1
Molecular Imaging of Monoamine Oxidase A Expression in Highly Aggressive Prostate Cancer: Synthesis and Preclinical Evaluation of Positron Emission Tomography Tracers.高侵袭性前列腺癌中单胺氧化酶A表达的分子成像:正电子发射断层显像剂的合成与临床前评估
ACS Pharmacol Transl Sci. 2023 Oct 25;6(11):1734-1744. doi: 10.1021/acsptsci.3c00175. eCollection 2023 Nov 10.
2
Prostate cancer autoantibodies - applications in diagnosis, prognosis, monitoring disease progression and immunotherapy.前列腺癌自身抗体——在诊断、预后、监测疾病进展及免疫治疗中的应用
Am J Clin Exp Urol. 2023 Apr 15;11(2):79-102. eCollection 2023.
3
The Role of PSMA PET/CT in the Primary Diagnosis and Follow-Up of Prostate Cancer-A Practical Clinical Review.
PSMA PET/CT在前列腺癌初诊及随访中的作用——一项实用临床综述
Cancers (Basel). 2022 Jul 26;14(15):3638. doi: 10.3390/cancers14153638.
4
Automatic multi-catheter detection using deeply supervised convolutional neural network in MRI-guided HDR prostate brachytherapy.在MRI引导的高剂量率前列腺近距离放射治疗中使用深度监督卷积神经网络进行自动多导管检测。
Med Phys. 2020 Sep;47(9):4115-4124. doi: 10.1002/mp.14307. Epub 2020 Jun 15.
5
Prognostic value of bone scan index as an imaging biomarker in metastatic prostate cancer: a meta-analysis.骨扫描指数作为转移性前列腺癌成像生物标志物的预后价值:一项荟萃分析。
Oncotarget. 2017 Jul 29;8(48):84449-84458. doi: 10.18632/oncotarget.19680. eCollection 2017 Oct 13.
6
Accuracy of dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate cancer: systematic review and meta-analysis.动态对比增强磁共振成像在前列腺癌诊断中的准确性:系统评价与荟萃分析
Oncotarget. 2017 Aug 17;8(44):77975-77989. doi: 10.18632/oncotarget.20316. eCollection 2017 Sep 29.
7
EpCAM Expression in Lymph Node and Bone Metastases of Prostate Carcinoma: A Pilot Study.EpCAM在前列腺癌淋巴结和骨转移中的表达:一项初步研究。
Int J Mol Sci. 2016 Sep 29;17(10):1650. doi: 10.3390/ijms17101650.
8
Imaging and Markers as Novel Diagnostic Tools in Detecting Insignificant Prostate Cancer: A Critical Overview.影像学和标志物作为检测微小前列腺癌的新型诊断工具:批判性综述
Int Sch Res Notices. 2014 Jul 15;2014:243080. doi: 10.1155/2014/243080. eCollection 2014.
9
Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience.使用多参数磁共振成像在前列腺癌风险适应性原发性放射治疗中指导治疗决策:单中心经验
Radiat Oncol. 2015 Feb 22;10:47. doi: 10.1186/s13014-015-0338-3.
10
Current approaches, challenges and future directions for monitoring treatment response in prostate cancer.前列腺癌治疗反应监测的当前方法、挑战及未来方向
J Cancer. 2014 Jan 1;5(1):3-24. doi: 10.7150/jca.7709.